Vascular endothelial growth factor polymorphisms increase the risk of developing Graves' disease
INTERNATIONAL IMMUNOPHARMACOLOGY, cilt.14, sa.2, ss.133-137, 2012 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 14 Sayı: 2
- Basım Tarihi: 2012
- Doi Numarası: 10.1016/j.intimp.2012.06.018
- Dergi Adı: INTERNATIONAL IMMUNOPHARMACOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.133-137
- İstanbul Üniversitesi Adresli: Evet
Özet
Background: Graves' disease (GD) is a consequence of genetic and environmental factors. Vascular endothelial growth factor (VEGF) is a strong angiogenic and mitogenic factor, which plays a key role in lymphocyte infiltration, and hypervascularization in the thyroid gland of patients with GD.